Gabon ANMAPS Trains Pharmaceutical Inspectors to Strengthen Supply Chain Compliance

Details of the Update

The initiative focuses on enhancing inspection and control standards by equipping inspectors with technical, legal, and methodological skills aligned with international inspection standards. The training spans the entire pharmaceutical supply chain, including manufacturing, importation, wholesale and retail distribution, dispensing activities, and fraud prevention. 

Inspectors are now trained to conduct inspections across all stages of the medicine supply chain, supporting more consistent and comprehensive regulatory oversight. The program also enables the development of new inspection protocols and standardized checklists tailored to different facility types, including pharmaceutical establishments, hospitals, and community pharmacies.

The initiative places increased emphasis on identifying critical risks and adapting inspection methods to specific operational contexts, improving the effectiveness of inspections across diverse operational settings. Regulatory oversight under this initiative applies to both human and veterinary medicines, as well as other regulated health products. 

The training was conducted in collaboration with REG-PHARMA, supporting national regulatory capacity building.

Effective Date

The inspector training took place from 16 to 20 February 2026, with enhanced inspection protocols expected to be implemented following the completion of the program.

Why It Matters

This initiative strengthens regulatory clarity and alignment with international inspection practices by standardizing inspector competencies and inspection methodologies. It supports more efficient and consistent oversight across the pharmaceutical supply chain while maintaining a proportionate compliance burden through clearer and more predictable inspection expectations.

Who This Is Relevant For

This update is relevant for Quality Assurance, Regulatory Affairs, Compliance, supply chain, and IT teams within pharmaceutical manufacturing, importation, distribution, and pharmacy operations in Gabon.

Next Steps

Stakeholders should review existing quality systems, distribution practices, and documentation against internationally aligned inspection standards. Organizations should also monitor ANMAPS communications for the release of new inspection protocols or checklists to inform internal compliance updates.

As inspection requirements become more structured and risk-focused, organizations may benefit from proactive regulatory intelligence. In this context, RegASK is a leading agentic AI regulatory intelligence and workflow orchestration platform that empowers global organizations in highly regulated sectors, including consumer products and life sciences, to proactively navigate complex regulatory landscapes. By combining advanced Agentic AI with experts in the loop, RegASK delivers timely predictive actionable insights and end-to-end automation, streamlining compliance processes, mitigating risks, and accelerating market access across more than 160 countries. Learn more or book a demo now. 

FAQs

What did ANMAPS announce on 24 February 2026? 

ANMAPS announced a national training initiative for pharmaceutical inspectors to strengthen inspection standards and regulatory compliance across Gabon’s medicine supply chain.

Which stages of the pharmaceutical supply chain are covered by the training?

The training covers manufacturing, importation, wholesale and retail distribution, dispensing activities, and fraud prevention.

Does the initiative apply to veterinary medicines?

Yes. The initiative applies to both human and veterinary medicines, as well as other regulated health products.

How can RegASK help organizations prepare for enhanced inspections in Gabon?

RegASK supports organizations by tracking regulatory developments, anticipating inspection expectations, and aligning internal compliance workflows through AI-driven regulatory intelligence combined with expert validation.